3, 4-Methylenedioxymethamphetamine (MDMA/ 'Ecstasy') Ingestion and Acute Liver Failure

被引：0
|
作者：
Mohamed, Zubair U. [1 ]
Willars, Chris [1 ]
Auzinger, Georg [1 ]
Heneghan, Michael [1 ]
Heaton, Nigel [1 ]
Wendon, Julia [1 ]
Bernal, William [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O-117
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [11] The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
    Green, AR
    Mechan, AO
    Elliott, JM
    O'Shea, E
    Colado, MI
    PHARMACOLOGICAL REVIEWS, 2003, 55 (03) : 463 - 508
  • [12] Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver
    Moon, Kwan-Hoon
    Upreti, Vijay V.
    Yu, Li-Rong
    Lee, Insong J.
    Ye, Xiaoying
    Eddington, Natalie D.
    Veenstra, Timothy D.
    Song, Byoung-Joon
    PROTEOMICS, 2008, 8 (18) : 3906 - 3918
  • [13] Detection of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) by displacement of antibodies
    Vikholm-Lundin, Inger
    Auer, Sanna
    Hellgren, Ann-Charlotte
    SENSORS AND ACTUATORS B-CHEMICAL, 2011, 156 (01) : 28 - 34
  • [14] The ecstasy and the agony; compression studies of 3,4-methylenedioxymethamphetamine (MDMA)
    Connor, Lauren E.
    Delori, Amit
    Hutchison, Ian B.
    Daeid, Niamh Nic
    Sutcliffe, Oliver B.
    Oswald, Iain D. H.
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2015, 71 : 3 - 9
  • [15] Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
    Parrott, AC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (01) : 71 - 83
  • [16] ACUTE-RENAL-FAILURE DUE TO ACCELERATED HYPERTENSION FOLLOWING INGESTION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY)
    WOODROW, G
    HARNDEN, P
    TURNEY, JH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (03) : 399 - 400
  • [17] Increased sensitivity to the acute effect of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") in female rats
    Votava, M
    Palenicek, T
    Bubenikova, V
    Dolezal, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S143 - S143
  • [18] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [19] 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY'): GENDER DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS
    Pardo-Lozano, R.
    Farre, M.
    Yubero-Lahoz, S.
    Torrens, M.
    Mustata, C.
    Perez-Mana, C.
    Menoyo, E.
    Perez, M.
    Martin, S.
    Cuyas, E.
    Civit, E.
    O'Mathuna, B.
    Carbo, M.
    de la Torre, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 51 - 52
  • [20] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
    Cohen, RS
    Cocores, J
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04): : 727 - 734
12345